Akari Therapeutics Plc (AKTX)
3.54
-0.93
(-20.81%)
USD |
NASDAQ |
Apr 06, 16:00
3.60
+0.06
(+1.69%)
After-Hours: 20:00
Akari Therapeutics SG&A Expense (TTM) : 9.294M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| DBV Technologies SA | 36.08M |
| Cellectis SA | 19.83M |
| Biodexa Pharmaceuticals Plc | 6.375M |
| Mereo BioPharma Group Plc | 23.06M |
| Bicycle Therapeutics Plc | 79.52M |